COX-2和NSAIDs与胰腺癌的关系
COX-2和NSAIDs与胰腺癌的关系
出处
《中国肿瘤临床与康复》
2006年第6期565-567,共3页
Chinese Journal of Clinical Oncology and Rehabilitation
参考文献2
-
1徐刚,吴恺,王兴鹏,赵崧.塞来昔布与吉西他滨合用对胰腺癌的抑制作用及其机制[J].中华医学杂志,2005,85(14):986-991. 被引量：17
-
2Lei Xu, You-Ming Li, Chao-Hui Yu, Lan Li, You-Shi Liu, Bao-Feng Zhang, Jing Fang, Qiong Zhou, Ying Hu and Hen-Jun Gao Department of Gastroenterology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China and National Engineering Center for Biochip, Shanghai 200000, China.Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray[J].Hepatobiliary & Pancreatic Diseases International,2006,5(1):138-142. 被引量：7
二级参考文献36
-
1Sven Eisold,Michael Linnebacher,EduardRyschich,DaliborAntolovic,UlfHinz,Ernst Klar,Jan Schmidt.The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines[J].World Journal of Gastroenterology,2004,10(24):3583-3589. 被引量：14
-
2Marx J. Anti-inflammatories inhibit cancer growth-but now? Science,2001,291:581-582.
-
3Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul, 1984,22:27-55.
-
4Ding H, Han C, Zhu J, et al. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Int J Cancer,2005 ;113:803-810.
-
5Cheng J, Imanishi H, Liu W, et al. Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatecellular carcinoma cell lines.Cancer Sci .2004,95,666-673.
-
6Grosch S, Tegeder I, Schilling K, et al. Activation of c-Jun-N-terminal-kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers.FASEB J,2003,17:1316-1318.
-
7Han C, Leng J, Demetris AJ, et al. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclcecygenase-2-indepent raechanism in celecexib-mediated induction of p21wafl/cipland p27kipl and cell cycle arrest. Cancer Res, 2004,64: 1369-1376.
-
8Mizutani Y, Nakanishi H, Li YN, et al. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522. J Urol, 2004,172:1474-1479.
-
9Lai GH, Zhang Z, Sifica AE. Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and-3. Mol Cancer Ther,2003 ,2 :265-271.
-
10Sweeney CJ. Why cyclooxygenase-2 inhibition plus chemotherapy?Am J Clin Oncol, 2003,26: S122-S125.
共引文献22
-
1赵可新,胡建平,单靖珊,马骐,葛军.盐酸吉西他滨临床应用进展[J].中国医药导报,2006,3(36):13-15. 被引量：12
-
2曹志成.中西医与分子靶向综合治疗胰腺癌的进展[J].世界华人消化杂志,2006,14(21):2049-2054. 被引量：5
-
3徐刚,王兴鹏,赵国旗,吴恺,赵崧.塞来昔布对胰腺癌的放疗增敏作用及其机制研究[J].中华消化杂志,2006,26(11):753-757. 被引量：7
-
4姚厚山,胡志前.细胞周期调节分子与胰腺癌发生、发展及预后的关系[J].肝胆胰外科杂志,2007,19(1):57-59.
-
5徐刚,王兴鹏,吴恺,赵崧.赛来昔布联合吉西他滨对胰腺癌细胞侵袭转移的抑制作用及其机制[J].中华肝胆外科杂志,2007,13(3):187-191. 被引量：4
-
6张群华,倪泉兴.努力推进胰腺癌规范治疗[J].中华医学杂志,2007,87(16):1086-1087. 被引量：8
-
7卢峪霞,陈锡美,郜恒骏.组织芯片在胰腺癌研究中的应用现状[J].胃肠病学,2008,13(10):629-631.
-
8张怡,蔡净亭,张瑜.选择性环氧合酶2抑制剂对子宫内膜癌细胞增殖能力及蛋白质表达谱的影响[J].中华妇产科杂志,2009,44(6):463-465.
-
9张群华.应进一步加强胰腺癌诊治研究[J].中华医学杂志,2009,89(34):2377-2380. 被引量：4
-
10张太平,杜潇,赵玉沛.重视对胰腺癌癌前病变的认识和处理[J].外科理论与实践,2009,14(5):546-549. 被引量：3
-
1黎润光,魏明发.Cox-2与胆道肿瘤的关系[J].临床肝胆病杂志,2006,22(1):76-77.
-
2赫银再,刘彦恒.环氧合酶-2与食管癌关系的研究进展[J].内蒙古医学杂志,2009,41(4):463-465.
-
3王兆钺,何杨.白血病花生四烯酸代谢的改变[J].中华血液学杂志,1993,14(1):31-32.
-
4谢传高.环氧合酶-2与消化系统肿瘤[J].国外医学（消化系疾病分册）,2002,22(1):20-22. 被引量：2
-
5马胜林,庞敏蓉.长期口服足叶乙甙治疗恶性肿瘤35例[J].河南肿瘤学杂志,1997,10(2):125-126.
-
6王磊,陈卫昌,杨吉成,郭继中.环氧合酶-2干扰对人结肠癌裸鼠移植瘤生长及血管形成的影响[J].中华实验外科杂志,2011,28(12):2097-2097. 被引量：1
-
7穆向明,陆寿耆,郑义同,杨成喜,吉亚君,徐光辉,卞宝祥,张为民.长期口服足叶乙甙和三苯氧胺治疗晚期肝癌临床观察[J].南通医学院学报,2001,21(1):42-43.
-
8郑荣娟,唐显赫,司雁菱,张志勇,吴瑜.环氧化酶2与大肠腺瘤性息肉癌变关系的研究[J].中国综合临床,2007,23(9):797-799.
-
9陈廷峰,王科明,施为建,潘勤,沈敬东.长期口服VP-16治疗复发或难治性肺癌46例[J].中国肿瘤临床,1997,24(1):54-55. 被引量：2
-
10高伟敏,檀艳丽,张颖,薛娟,刘书哲.环氧化酶-2在大肠癌的表达及相关性研究[J].医学研究与教育,2009,26(4):89-92.
